Latest Breaking News On - Yme disease vaccine moves to phase iii as booster trial proves effective - Page 1 : comparemela.com

The Phase II trial, VLA150202, evaluated the safety and immunogenicity of VLA15 on 246 healthy adults aged 18 to 65 years old across the United States.

United statesKathrin jansenPfizer vaccine researchOspa iggNorthern hemisphereFast trackDrug administrationYme disease vaccine moves to phase iii as booster trial proves effective